Task: Answer the multiple choice question.
Question: Which compound exhibits a -21.233\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCN(CC)C(=O)C(=O)N/N=C/c1ccc(Cl)cc1Cl
b. COc1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(Cl)c1OC(C)C
c. CN(CCC(=O)Nc1ccc(Cl)cc1)Cc1ccccc1.Cl
Answer: b. COc1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(Cl)c1OC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(Cl)c1OC(C)C
COc1cc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc(Cl)c1OC(C)C
N-(1-benzylpiperidin-4-yl)-3-chloro-5-methoxy-4-propan-2-yloxybenzamide